DRTS – alpha tau medical ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Alpha Tau Medical (NASDAQ:DRTS) had its price target lowered by analysts at Citigroup Inc. from $8.00 to $7.00. They now have a "buy" rating on the stock.
Alpha Tau Medical (NASDAQ:DRTS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
Form 144 Alpha Tau Medical Ltd. Filed by: Gat Amnon
Form 6-K Alpha Tau Medical Ltd. For: Dec 09
Form 6-K Alpha Tau Medical Ltd. For: Dec 04
Form 6-K Alpha Tau Medical Ltd. For: Dec 02
Form 144 Alpha Tau Medical Ltd. Filed by: Gat Amnon
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.